The pharmacological inhibition of LPAR1 with Ki16425 in LDLR-/- apoB 100/100 IGFII mice reduced the progression of CAVD and downregulated the expression of BMP2 in aortic valve cusps [38]. Here, IGF2 is linked to congenital bilateral aplasia of vas deferens from CFTR mutation.